HC Wainwright & Co. Reiterates Buy on Pulmatrix, Maintains $10 Price Target
Benzinga Newsdesk 3 years ago
NewsPrice TargetReiterationAnalyst Ratings
HC Wainwright & Co. analyst Andrew Fein reiterates Pulmatrix (NASDAQ:PULM) with a Buy and maintains $10 price target.
HC Wainwright & Co. analyst Andrew Fein reiterates Pulmatrix (NASDAQ:PULM) with a Buy and maintains $10 price target.